Interference of biochemically important reducing agents with the diazotation of sulfanilamide.

Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Abstract Text:

H R SCHREINER,A P RINFRET,

Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Publishing Authors By Initials

HR SCHREINER,AP RINFRET,

For similar enzymes and coenzymes: coenzymes research abstracts see: enzymes and coenzymes: coenzymes research

PUBMED ID PMID:

MEDLINE DATE:

Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Biochimica et biophysica acta

VOLUME: 39

Page Numbers: 343-5

Journal Abbreviation: Biochim. Biophys. Acta

ISSN: 0006-3002

DAY: 8

MONTH: Apr

YEAR: 1960

Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 217513

Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Keywords Mesh Terms:

KEYWORDS: Coenzymes

MESH TERMS: chemistry

Chemical & Substance for Abstract: Interference of biochemically important reducing agents with the diazotation of sulfanilamide. Information

Substance Name: sulfanilamide

Registry Number: 63-74-1

Grant and Affiliation Information for Interference of biochemically important reducing agents with the diazotation of sulfanilamide.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Biochim Biophys Acta

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Interference of biochemically important reducing agents with the diazotation of sulfanilamide Related Publications

• Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.
• Interference of biochemically important reducing agents with the diazotation of sulfanilamide.
• Left main coronary artery occlusion with myocardial infarction in a cocaine user. Successful angioplasty with a drug-eluting stent.
• Restrictive access to clopidogrel and mortality following coronary stent implantation.
• The unresolved issues with risk stratification and management of patients with coronary artery disease undergoing major vascular surgery: [Questions non resolues concernant la stratification du risque et la prise en charge des patients atteints de maladie
• [Not Available.]
• [Not Available.]